Jul. 7 at 11:40 AM
$OGN Organon announces American Academy of Dermatology recommendation for Vtama cream
Organon announced that Vtama cream, 1%, was granted a recommendation by the American Academy of Dermatology in their 2025 focused guideline update for the management of adults with moderate to severe atopic dermatitis. The recommendation underscores Vtama cream as an effective, steroid-free option for daily disease management, with no label warnings or precautions, no contraindications, and no restrictions on duration of use or percentage of body surface area affected.